From: Endoscopic vacuum therapy for postoperative esophageal leak
Variables | |
---|---|
Patients (n = 20) | |
Male | 20 (100.0) |
Age, years | 66.5 (53–77) |
WBC, ×103/uL | 8.59 (5.59–17.48) |
CRP, mg/dL | 6.85 (0.58–26.74) |
Organ failure | 2 (10.0) |
CCI score | |
0 | 14 (70.0) |
1–3 | 6 (30.0) |
Neoadjuvant treatment | |
No | 10 (50.0) |
Yes | 10 (50.0) |
Operation | |
Ivor-Lewis operation | 7 (35.0) |
3-field lymph node dissection | 8 (40.0) |
McKeown operation | 4 (20.0) |
Transhiatal esophagectomy | 1 (5.0) |
Anastomosis | |
Intrathoracic anastomosis | 13 (65.0) |
Cervical anastomosis | 7 (35.0) |
Anastomotic leak | |
Time to diagnosis, days | 12.5 (5–35) |
Fistula size, cm | 1.75 (0.5–3.0) |
Mucosal ischemia on EGD | 16 (80.0) |
EVAC treatment | |
Time to treatment, days | 3 (0–24) |
Duration of EVAC, days | 14.5 (4–56) |
Number of interventions | 5 (2–12) |
Treatment failure | 1 (5.0) |
Hospital stay, days | 49 (19–90) |
Mortality | 1 (5.0) |